K. Sanogo

发表

Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.

A. Dicko, H. Tinto, J. Ouédraogo, 2021, The New England journal of medicine.

The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone

A. Dicko, H. Tinto, J. Ouédraogo, 2022, BMC Medicine.

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine

A. Dicko, H. Tinto, J. Ouédraogo, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention

A. Dicko, H. Tinto, J. Ouédraogo, 2020, BMJ Open.

Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali.

A. Dicko, T. Bousema, S. Traore, 2024, The Lancet. Microbe.

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial

A. Dicko, Joelle M. Brown, T. Bousema, 2018, The Journal of infectious diseases.

Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.

A. Dicko, Joelle M. Brown, T. Bousema, 2016, The Lancet. Infectious diseases.

Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial

A. Dicko, T. Bousema, C. Drakeley, 2021, The Lancet. Microbe.

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial

A. Dicko, T. Bousema, C. Drakeley, 2022, The Lancet. Microbe.

Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial

A. Dicko, O. Müller, Joelle M. Brown, 2018, The Lancet. Infectious diseases.

Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouelessebougou, Mali: a five-arm, phase 2, single-blind, randomised clinical trial

A. Dondorp, K. Teelen, S. M. Niambele, 2024, medRxiv.

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

A. Dicko, A. Olotu, H. Tinto, 2024, The Lancet.

Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial.

A. Dicko, H. Tinto, J. Ouédraogo, 2023, The Lancet. Infectious diseases.

Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali

A. Dicko, M. Thera, A. Djimde, 2021, Tropical medicine and infectious disease.

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians

A. Dicko, T. Bousema, C. Drakeley, 2021, Malaria journal.

Persistence of P. Falciparum Ring-stage Parasites 42 Days After Artemisinin and Non-artemisinin Combination Therapy in Naturally Infected Malians

A. Dicko, T. Bousema, C. Drakeley, 2020 .

Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger

A. Dicko, O. Doumbo, R. Grais, 2016, BMC Medicine.